Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Dandruff is mainly caused by a scalp reaction to yeast, can worsen hair loss, and antifungal treatments may help.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

COVID-19 may cause hair loss due to infection stress or treatments.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Oral minoxidil helps hair growth, is cost-effective, and mostly well-tolerated.

The conclusion is that exogen is a unique hair cycle phase and the new sampling method specifically targets this stage, which may help in future hair loss research.

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

Hair or fiber wrapped tightly around a toe can lead to serious injury if not treated quickly.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Men typically shed about 10 hairs in 60 seconds, and this amount doesn't increase with age.

Lithium therapy may cause temporary hair loss, with possible regrowth if treatment is stopped or continued.

Oral contraceptives may cause hair loss in women.